skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Peptide and protein biomarkers for type 1 diabetes mellitus

Patent ·
OSTI ID:1311866

A method for identifying persons with increased risk of developing type 1 diabetes mellitus, or having type I diabetes mellitus, utilizing selected biomarkers described herein either alone or in combination. The present disclosure allows for broad based, reliable, screening of large population bases. Also provided are arrays and kits that can be used to perform such methods.

Research Organization:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC05-76RL01830
Assignee:
Battelle Memorial Institute (Richland, WA)
Patent Number(s):
9,429,569
Application Number:
14/268,002
OSTI ID:
1311866
Resource Relation:
Patent File Date: 2014 May 02
Country of Publication:
United States
Language:
English

References (37)

Method for identifying type I diabetes mellitus in humans patent-application May 2009
Protein biomarkers and therapeutic targets for autoimmune and alloimmune diseaes patent-application March 2012
Composition and Methods for Diagnosis and Prognosis of Colorectal Cancer patent-application June 2012
Methods for Detecting Pre-Diabetes and Diabetes Using Differential Protein Glycosylation patent-application August 2012
Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins journal December 2005
Prediction of Autoantibody Positivity and Progression to Type 1 Diabetes: Diabetes Autoimmunity Study in the Young (DAISY) journal August 2004
Diabetes Antibody Standardization Program: First Assay Proficiency Evaluation journal May 2003
Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories journal July 2010
Plasma Gelsolin: Function, Prognostic Value, and Potential Therapeutic Use journal December 2008
Normalization Approaches for Removing Systematic Biases Associated with Mass Spectrometry and Label-Free Proteomics journal February 2006
Type 1 diabetes: entering the proteomic era journal April 2006
Proteomics and naturally occurring animal diseases: Opportunities for animal and human medicine journal February 2008
Development of a fibrinogen-specific sandwich enzyme-linked immunosorbent assay microarray assay for distinguishing between blood plasma and serum samples journal July 2011
The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants journal May 2011
Comparative aspects of diabetes mellitus in dogs and cats journal November 2002
High-Abundance Polypeptides of the Human Plasma Proteome Comprising the Top 4 Logs of Polypeptide Abundance journal August 2008
Decon2LS: An open-source software package for automated processing and visualization of high resolution mass spectrometry data journal January 2009
Environmental Triggers and Determinants of Type 1 Diabetes journal November 2005
Thrombocidins, Microbicidal Proteins from Human Blood Platelets, Are C-terminal Deletion Products of CXC Chemokines journal June 2000
Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma journal May 2009
Potentiation of C1 Esterase Inhibitor by StcE, a Metalloprotease Secreted by Escherichia coli O157:H7 journal April 2004
Fully Automated Four-Column Capillary LC−MS System for Maximizing Throughput in Proteomic Analyses journal January 2008
Effect of Collision Energy Optimization on the Measurement of Peptides by Selected Reaction Monitoring (SRM) Mass Spectrometry journal December 2010
Application of Proteomics in the Discovery of Candidate Protein Biomarkers in a Diabetes Autoantibody Standardization Program Sample Subset journal February 2008
VIPER: an advanced software package to support high-throughput LC-MS peptide identification journal June 2007
Interpretation of Shotgun Proteomic Data: The Protein Inference Problem journal July 2005
Improved Peptide Elution Time Prediction for Reversed-Phase Liquid Chromatography-MS by Incorporating Peptide Sequence Information journal July 2006
Primer: Immunity and Autoimmunity journal October 2008
Targeted proteomic strategy for clinical biomarker discovery journal December 2008
Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies journal September 2010
Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome journal February 2011
Enterovirus Infection and Progression From Islet Autoimmunity to Type 1 Diabetes: The Diabetes and Autoimmunity Study in the Young (DAISY) journal September 2010
Insulin-Dependent Diabetes Mellitus journal May 1996
Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2 journal March 2008
An Inflammatory Gene-Expression Fingerprint in Monocytes of Autoimmune Thyroid Disease Patients
  • van der Heul-Nieuwenhuijsen, Leonie; Padmos, Roos C.; Drexhage, Roosmarijn C.
  • The Journal of Clinical Endocrinology & Metabolism, Vol. 95, Issue 4 https://doi.org/10.1210/jc.2009-1455
journal April 2010
Prediction of Low-Energy Collision-Induced Dissociation Spectra of Peptides journal July 2004
Advances in proteomics data analysis and display using an accurate mass and time tag approach journal January 2006

Similar Records

Peptide and protein biomarkers for type 1 diabetes mellitus
Patent · Tue Jun 10 00:00:00 EDT 2014 · OSTI ID:1311866

Serum markers for type II diabetes mellitus
Patent · Tue Mar 18 00:00:00 EDT 2014 · OSTI ID:1311866

MicroRNAs as biomarkers of diabetic retinopathy and disease progression
Journal Article · Fri Nov 01 00:00:00 EDT 2019 · Neural Regeneration Research · OSTI ID:1311866